A delegation from the National Comprehensive Cancer Network, including Northwestern oncology leaders, recently met with health leaders in Bolivia to begin generating cancer treatment recommendations to fit the country’s unique needs.
Northwestern scientists recently identified a new protein complex that is upregulated in acute myeloid leukemia, potentially explaining why current therapies are often ineffective.
More than 450 scientists, trainees, students and faculty presented posters and abstracts at Feinberg’s 15th Annual Lewis Landsberg Research day — the largest celebration of scientific investigation at Feinberg to date.
Kathleen Green, PhD, the Joseph L. Mayberry, Sr., Professor of Pathology and Toxicology and professor of Dermatology, has been named the winner for the 2019 Tripartite Legacy Faculty Prize in Translational Science and Education.
A new study has uncovered a key mechanism underlying the control of a co-factor that is essential for all cells to grow and divide, and which may also play a key role in cancer cell growth.
Hossein Ardehali, MD, PhD, was elected president of the American Society for Clinical Investigation, an honor society of physician-scientists founded in 1908.
A recent Northwestern Medicine study found that patients with glioblastoma responded better or worse to immunotherapy depending on the presence of certain mutations in their tumors.
Ankit Bharat, MBBS, the Harold L. & Margaret N. Method Research Professor of Surgery, has been named chief of Thoracic Surgery in the Department of Surgery.
Northwestern Medicine investigators discovered a method to modulate levels of a protein that is known to drive inflammation, by manipulating levels of an amino acid known as serine.
According to a recent study, Northwestern scientists have pinpointed how an ectoenzyme called CD73 undermines the effectiveness of an emerging cancer therapy.